Active, Not RecruitingPhase 2ketamine
Understanding How Ketamine Brings About Rapid Improvement in OCD
Sponsored by Stanford University
NCT ID
NCT02624596
Target Enrollment
120 participants
Start Date
2016-06
Est. Completion
2026-06
About This Study
The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.
Conditions Studied
Interventions
- •Ketamine
- •Midazolam
Eligibility
Age:18 Years - 65 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria for participants with OCD: * age 18-65 * Primary diagnosis of OCD * Sufficient severity of OCD symptoms * ability to tolerate a treatment-free period * capacity to provide informed consent Inclusion criteria for healthy controls: * ages 18-65 * capacity to provide informed consent Exclusion criteria for participants with OCD: * Psychiatric or medical conditions that make participation unsafe * pregnant or nursing females * concurrent use of any medications that might increase the risk of participation (e.g. drug interactions) * presence of metallic device or dental braces Exclusion criteria for healthy controls: * any current or lifetime psychiatric diagnosis * pregnant or nursing females * major medical or neurological problem * presence of metallic device or dental braces
Study Locations (1)
Stanford University
Stanford, California, United States